BioNxt Solutions Inc., a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally ...

The BioNxt Advantage Despite Semaglutide's success, its injectable format presents barriers, including needle anxiety and challenges with long-term adherence. BioNxt's sublingual thin-film ...

The result is the growth of a niche industry of so-called compounding pharmacies selling “homemade” versions of these weight loss drugs: compounded semaglutide (as a substitute for Ozempic or ...

The addition of sublingual semaglutide to Found's medication formulary delivers several key innovations: On the importance of expanding treatment options, Board Member Dena Bravata, MD ...